COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 494

Article download: 152

Panacea Journal of Medical Sciences

Menopause and the metabolic syndrome

Full Text PDF Share on Facebook Share on Twitter

Author Details : Almeida Joylene

Volume : 5, Issue : 3, Year : 2015

Article Page : 158-160

Suggest article by email


Menopause is the period in a woman’s life when she is undergoing hormonal and metabolic changes. Metabolic syndrome or syndrome X comprises of a set of cardiovascular risk factors: obesity, elevated blood pressure, hyperglycemia or insulin resistance and dyslipidemia. Menopause is the point in the timeline of a woman where she is exposed to risk factors for cardiac ill health. The preferential central pattern of fat deposition in obese post-menopausal women is associated with a higher risk of diabetes, hypertriglyceridemia, hypertension and cardiac disease. Hormone therapy improves the altered lipid profile in women with metabolic syndrome and these effects are more pronounced in post-menopausal women. It is important to have more efforts for regular lipid screening and educational programs for a healthy life style for an obese post-menopausal woman.

: Metabolic syndrome, Menopause, Hormone therapy.

How to cite : Joylene A, Menopause and the metabolic syndrome. Panacea J Med Sci 2015;5(3):158-160

Copyright © 2015 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (